Lacrimal sac lymphoma: a case series and literature review
Author:
Corresponding Author:

Jiang Qian. Department of Ophthalmology, Eye & ENT Hospital of Fudan University, Shanghai 200031, China. qianjiang58@hotmail.com

Affiliation:

Clc Number:

Fund Project:

Supported by the National Natural Science Foundation of China (No.81970835); the Science and Technology Commission of Shanghai Municipality, China (No.20Y11911200).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To study the clinical and pathological characteristics of the lacrimal sac lymphoma, which is rare but it is the major type of non-epithelial malignant tumor in the lacrimal sac region. METHODS: Sixty-four cases of malignant lacrimal sac tumors in our hospital from 1986 to 2020 were retrospectively reviewed. Eight cases of lacrimal sac lymphoma were carefully reviewed. RESULTS: There were five mucosal-associated lymphoid tissue (MALT) lymphomas, one diffused large B-cell lymphoma, one NK/T cell lymphoma, and one mantle cell lymphoma. All eight patients represented symptoms of epiphora with swelling in the lacrimal sac for a certain period of time and showed no signs of systemic involvement at the first time of clinical visits. They had received either chemotherapy or radiotherapy after surgery. Long-term follow-up (from 11 to 220mo) showed that, except one patient with MALT lymphoma died for unknown reasons at 104mo after surgery, the other 7 patients were all alive with no signs of local recurrence, neither in other organs. CONCLUSION: Non-epithelial malignant tumors of the lacrimal sac are rare and lymphoma is the major subtype.

    Reference
    Related
    Cited by
Get Citation

Feng-Xi Meng, Han Yue, Yi-Qun Yuan, et al. Lacrimal sac lymphoma: a case series and literature review. Int J Ophthalmol, 2022,15(10):1586-1590

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:September 25,2021
  • Revised:June 20,2022
  • Adopted:
  • Online: September 21,2022
  • Published: